Lanorinal

   
Google
 
Web NewDrugInformation.com

Lanorinal


Drug - Lanorinal
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Aspirin; Butalbital; Caffeine
Multiple ingredients are in alphabetical order.

Strength - 325MG;50MG;40MG
The potency of the active ingredient(s), Aspirin; Butalbital; Caffeine. May repeat for multiple part products.

Applicant - LANNETT
The firm name holding legal responsibility for Lanorinal. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 086986
The FDA assigned number to Lanorinal. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Lanorinal. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 18, 1985
The date Lanorinal was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Lanorinal. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Lanorinal is in. Format is RX, OTC, DISCN.

Applicant Full Name - Lannett Co Inc
The full name of the firm holding legal responsibility for the new application of Lanorinal.

Lanorinal